NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01219920,FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer,https://clinicaltrials.gov/study/NCT01219920,,COMPLETED,The purpose of the study is to evaluate if the exposure to all the three active cytotoxic agents (FOLFOXIRI regimen) is superior in terms of response rate to conventional chemotherapy with the FOLFIRI regimen as first-line treatment of metastatic colorectal cancer patients.,NO,Metastatic Colorectal Cancer,DRUG: FOLFIRI|DRUG: FOLFOXIRI,"Response rate (RR), Responses are evaluated every 8 weeks according to WHO criteria. The determination of responses and progression was initially based on investigator-reported measurements; computed tomography scans of all responding patients and of patients with stable disease were subsequently subjected to external review by an independent panel., Responses are evaluated every 8 weeks according to WHO criteria and reviewed by an independent panel at the end of treatment (6 months)","Progression-free survival (PFS), PFS is defined as the length of time from random assignment to disease progression or to death resulting from any cause, whichever occurred first, or to last contact., Progressions are evaluated every 8 weeks according to WHO criteria and reviewed by an independent panel at the end of follow up (36 months)|Overall survival (OS), OS is defined as the length of time from random assignment to death or to last contact., For survival analysis participants are followed until death|Postchemotherapy radical (R0) surgical resection rate of metastases, Percentage of patients who undergo radical (R0) resection of metastases after achieving objective response to chemotherapy., Postchemotherapy radical (R0) surgical resection rate of metastases were evaluated every 8 weeks during treatment and during follow up (36 months)|Number of Participants with Adverse Events as a Measure of Safety and Tolerability, During the full lenght of first-line treatment, number of enrolled patients reporting adverse events is recorded. Adverse events are evaluated according to National Cancer Institute Common Toxicity Criteria version 2.0., Number of Participants with Adverse Events as a Measure of Safety and Tolerability were evaluated every 2 weeks during treatment and every 8 weeks during follow up (36 months)|Quality of life (QoL), Quality of life is assessed at the beginning of each treatment cycle using the Quality of Life Questionnaire of the European Organisation for Research and Treatment of Cancer (version 2.0).

The QLQ-C30 questionnaire was analyzed with the global health status/quality-of-life scale as the primary end point and the other 10 scales as secondary end points., Quality of life was evaluated every 2 weeks during treatment and every 8 weeks during follow up (36 months)",,Gruppo Oncologico del Nord-Ovest,,ALL,"ADULT, OLDER_ADULT",PHASE3,244,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,ASL601LIOM03|2007-002886-11,2001-11,2005-11,2009-11,2010-10-13,,2015-03-11,"Ospedale Civile Ss. Antonio E Biagio Di Alessandria - Alessandria (Al) Oncologia Medica, Alessandria, 15100, Italy|A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona - Ancona (An) Oncologia Medica, Ancona, 60100, Italy|Ausl Della Valle D' Aosta (Ao) - Aosta (Ao) Oncologia Medica, Aosta, 11100, Italy|P.O. Zona Aretina - Ospedale S. Donato Di Arezzo - Arezzo (Ar) Oncologia Medica, Arezzo, 52100, Italy|Azienda Ospedale 'G.Rummo' - Benevento (Bn) Oncologia Medica, Benevento, 82100, Italy|Ospedale Degli Infermi Di Biella - Biella (Bi) Oncologia Medica, Biella, 13900, Italy|Ospedale S. Orsola F.B.F. - Brescia - Brescia (Bs) Oncologia Medica, Brescia, 25122, Italy|Stabilimento ""Perrino"" - Brindisi - Brindisi (Br) Oncologia Medica, Brindisi, 72100, Italy|Azienda Ospedaliera S. Elia - Caltanissetta (Cl) Oncologia Medica, Caltanissetta, 93100, Italy|Ospedale Versilia - Camaiore (Lu) Oncologia Medica, Camaiore, 55043, Italy|Ospedale Cecina - Cecina (Li) Oncologia Medica, Cecina, 57023, Italy|Istituti Ospitalieri - Cremona - Cremona (Cr) Oncologia Medica, Cremona, 26100, Italy|Azienda Ospedaliera S. Croce E Carle Di Cuneo - Cuneo (Cn) Oncologia Medica, Cuneo, 12100, Italy|Ausl 11 Di Empoli (Fi) - Empoli (Fi) Oncologia Medica, Empoli, 50053, Italy|Asur - Zona Territoriale 6 Di Fabriano (An) - Fabriano (An) Oncologia Medica, Fabriano, 60044, Italy|Ospedale Santa Croce Fano - Fano (Pu) Oncologia Medica, Fano, 61032, Italy|Ausl 10 Di Firenze - Firenze (Fi) Oncologia Medica, Firenze, 50122, Italy|A.O. Universitaria Careggi Di Firenze Oncologia Medica, Firenze, 50134, Italy|E.O. Ospedali Galliera - Genova (Ge) Oncologia Medica, Genova, 16128, Italy|Irccs Istituto Nazionale Per La Ricerca Sul Cancro (Ist) - Genova (Ge) Oncologia Medica, Genova, 16132, Italy|Ospedale Sant'Andrea La Spezia - La Spezia (Sp) Oncologia Medica, La Spezia, 19100, Italy|Ausl Le Di Lecce - Lecce (Le) Oncologia Chirurgica, Lecce, 73100, Italy|Ospedale Per Acuti ""Mater Salutis"" Legn. - Legnago (Vr) Oncologia Medica, Legnano, 37045, Italy|U.O. Oncologia Medica, Ospedale Civile, Livorno, 57123, Italy|Presidio Ospedaliero Piana Di Lucca - Lucca (Lu) Oncologia Medica, Lucca, 55100, Italy|Irccs Fondazione Centro S. Raffaele Del Monte Tabor - Milano (Mi) Oncologia Medica, Milano, 20132, Italy|Ospedale Ca' Granda-Niguarda - Milano - Milano (Mi) Oncologia Medica, Milano, 20162, Italy|Ospedale Civile Di Mirano - Mirano (Ve) Oncologia Medica, Mirano, 30035, Italy|A.O. Universitaria Federico Ii Di Napoli Oncologia Medica, Napoli, 80131, Italy|A.O. Universitaria Maggiore Della Carita' Di Novara Oncologia Medica, Novara, 28100, Italy|A.O. Universitaria Di Parma Oncologia Medica, Parma, 43100, Italy|Asl 1 Di Citta' Di Castello (Pg) - Citta' Di Castello (Pg) Oncologia Medica, Perugia, 06012, Italy|A.O. Di Perugia - Ospedale S. Maria Della Misericordia (Ex Silvestrini) - Perugia (Pg) Oncologia Medica, Perugia, 06156, Italy|Azienda Ospedaliera San Salvatore - Pesaro (Pu) Oncologia Medica, Pesaro, 61100, Italy|Ospedale Piombino - Piombino (Li) Oncologia Medica, Piombino, 57025, Italy|Ausl 5 Di Pisa - Pisa (Pi) Oncologia Medica, Pisa, 56100, Italy|A.O. Universitaria Pisana - Pisa (Pi) Oncologia Medica, Pisa, 56126, Italy|A.O. Universitaria Pisana Oncologia Medica, Pisa, 56126, Italy|Ausl 3 Di Pistoia - Pistoia (Pt) Oncologia Medica, Pistoia, 51100, Italy|Ospedali Riuniti Di Pistoia - Pistoia (Pt) Oncologia Medica, Pistoia, 51100, Italy|Ospedale Di S. Maria Nuova - Reggio Nell'Emilia, Reggio Emilia, 42100, Italy|Policlinico Universitario Campus Bio-Medico Di Roma Oncologia Medica, Roma, 00128, Italy|Policlinico Umberto I Di Roma Oncologia Medica, Roma, 00161, Italy|Policlinico Universitario Gemelli Di Roma Oncologia Medica, Roma, 00168, Italy|A.O. Universitaria Senese Oncologia Medica, Siena, 53100, Italy|Ausl 7 Di Siena - Siena (Si) Oncologia Medica, Siena, 53100, Italy|Ospedale Civile - Sondrio - Sondrio (So) Oncologia Medica, Sondrio, 23100, Italy|A.O. Universitaria S. Giovanni Battista-Molinette Di Torino Oncologia Medica, Torino, 10134, Italy",
